Citation Impact
Citing Papers
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
2023 Standout
Repurposing Antidepressants and Phenothiazine Antipsychotics as Efflux Pump Inhibitors in Cancer and Infectious Diseases
2023
Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms.
2017 Standout
Review on plant antimicrobials: a mechanistic viewpoint
2019 Standout
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
2019 Standout
Mental distress in the Danish general population
2006
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
2011
Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research
2011
Pseudomonas Aeruginosa: Resistance to the Max
2011 Standout
Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli
2011
Synthetic organic dyes as contaminants of the aquatic environment and their implications for ecosystems: A review
2020 Standout
Psychiatric outcome studies (POS): Does treatment help the patients? A Popperian approach to research in clinical psychiatry
2007
TYGS is an automated high-throughput platform for state-of-the-art genome-based taxonomy
2019 Standout
Phenothiazine: the seven lives of pharmacology's first lead structure
2011
Antibiotic resistance and its cost: is it possible to reverse resistance?
2010 Standout
Systems-level antimicrobial drug and drug synergy discovery
2013
Modulating antibiotic activity towards respiratory bacterial pathogens by co-medications: a multi-target approach
2016
Subjective wellbeing, health, and ageing
2014 StandoutNobel
Implant infections: adhesion, biofilm formation and immune evasion
2018 Standout
Efflux-Mediated Drug Resistance in Bacteria
2009
Post-Traumatic Growth After a Myocardial Infarction: A Matter of Personality, Psychological Health, or Cognitive Coping?
2008 Standout
Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation
2020 StandoutNobel
Antibacterial drug discovery in the resistance era
2016 StandoutNature
Genome-Based Taxonomic Classification of the Phylum Actinobacteria
2018 Standout
The WHO-5 Well-Being Index: A Systematic Review of the Literature
2015 Standout
Targeting Energy Metabolism in Mycobacterium tuberculosis , a New Paradigm in Antimycobacterial Drug Discovery
2017
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Synergistic Efficacy of Aedes aegypti Antimicrobial Peptide Cecropin A2 and Tetracycline against Pseudomonas aeruginosa
2017
Antibiotics and Bacterial Resistance in the 21st Century
2014 Standout
Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action
2017 Standout
Antimicrobial Activity of Some Essential Oils—Present Status and Future Perspectives
2017 Standout
Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry in Clinical Microbiology: What Are the Current Issues?
2017
Antimicrobial activity of phenothiazines.
2005
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis
2017 StandoutNobel
Works of Oliver Hendricks being referenced
Depression assessed over 1‐year survival in patients with myocardial infarction
2006
Psychosocial predictors of depression in patients with acute coronary syndrome
2004
The in-vitro antimicrobial effect of non-antibiotics and putative inhibitors of efflux pumps on Pseudomonas aeruginosa and Staphylococcus aureus
2003
Reversal of resistance in microorganisms by help of non-antibiotics
2007
In vitro Activity of Phenothiazine Derivatives in Enterococcus faecalis and Enterococcus faecium
2005
Phenothiazines as a solution for multidrug resistant tuberculosis: From the origin to present.
2015
Mycobacterium alsense sp. nov., a scotochromogenic slow grower isolated from clinical respiratory specimens
2015